WEBVTT - EBOS Group: Pills, pets, and pharmacies

0:00:00.819 --> 0:00:06.290
<v Speaker 1>This episode was recorded on Wurundjeri, Woiwurrung land. We acknowledge

0:00:06.570 --> 0:00:10.110
<v Speaker 1>and pay our respects to the traditional owners of this country,

0:00:10.369 --> 0:00:14.250
<v Speaker 1>past and present. This episode is brought to you by

0:00:14.330 --> 0:00:22.520
<v Speaker 1>Sharesies Australia Limited, AFSL 529893 in Australia and Sharesies Limited

0:00:22.739 --> 0:00:26.680
<v Speaker 1>in New Zealand. This is general advice only. and doesn't

0:00:26.739 --> 0:00:31.640
<v Speaker 1>take into account your personal objectives, financial situation or needs.

0:00:32.620 --> 0:00:35.890
<v Speaker 1>Welcome to Shared Lunch. Today, we're at the eBoss Group

0:00:35.990 --> 0:00:40.550
<v Speaker 1>offices in Melbourne with the CEO, Adam Hall. eBoss is

0:00:40.610 --> 0:00:46.210
<v Speaker 1>the largest and most diversified healthcare, medical and pharmaceutical distributor

0:00:46.409 --> 0:00:50.050
<v Speaker 1>in Australia and New Zealand, and a leading owner of

0:00:50.190 --> 0:00:56.000
<v Speaker 1>animal care brands. eBoss's consumer reach is significant spanning the

0:00:56.060 --> 0:00:59.520
<v Speaker 1>Terry White Chem Mart pharmacy network, as well as pet

0:00:59.560 --> 0:01:04.640
<v Speaker 1>care staples like Blackhawk and Vitapet. The group generates around

0:01:04.640 --> 0:01:09.850
<v Speaker 1>$ 13 billion in annual revenue and employs over 5,000 people

0:01:10.010 --> 0:01:15.770
<v Speaker 1>across Australia, New Zealand and Southeast Asia. Adam Hall stepped

0:01:15.930 --> 0:01:18.610
<v Speaker 1>into the CEO role a little over a year ago,

0:01:18.630 --> 0:01:21.570
<v Speaker 1>and so it's a fitting time to sit down with him.

0:01:22.410 --> 0:01:25.429
<v Speaker 2>Investing involves risk. You might lose the money you start with.

0:01:25.810 --> 0:01:29.530
<v Speaker 2>We recommend talking to a licensed financial advisor. We also

0:01:29.590 --> 0:01:33.509
<v Speaker 2>recommend reading product disclosure documents before deciding to invest. Everything

0:01:33.530 --> 0:01:35.580
<v Speaker 2>you're about to see and hear is current at the

0:01:35.620 --> 0:01:36.280
<v Speaker 2>time of recording.

0:01:36.400 --> 0:01:39.860
<v Speaker 1>Adam, thank you for joining us and welcome to Shared Lunch.

0:01:40.160 --> 0:01:40.520
<v Speaker 3>Thanks, Jackie.

0:01:40.740 --> 0:01:43.860
<v Speaker 1>You stepped into the CEO role a little over a

0:01:43.940 --> 0:01:44.460
<v Speaker 1>year ago.

0:01:44.480 --> 0:01:44.560
<v Speaker 3>Yeah.

0:01:45.200 --> 0:01:48.480
<v Speaker 1>You've had a career that's taken you through law, strategy

0:01:48.720 --> 0:01:49.550
<v Speaker 1>and consulting.

0:01:49.560 --> 0:01:49.690
<v Speaker 3>Yeah.

0:01:50.190 --> 0:01:54.930
<v Speaker 1>You've previously held executive roles at a global agribusiness and

0:01:54.970 --> 0:01:59.130
<v Speaker 1>also a chemical business. What shaped your decision to join

0:01:59.170 --> 0:02:00.450
<v Speaker 1>as the CEO of eBoss?

0:02:00.810 --> 0:02:04.090
<v Speaker 3>Yeah, and it's a little bit of a tangled path.

0:02:04.150 --> 0:02:05.710
<v Speaker 3>So if I walk through it from the beginning, I

0:02:06.470 --> 0:02:11.540
<v Speaker 3>grew up between Perth and Karratha in Australia. And then

0:02:11.600 --> 0:02:13.780
<v Speaker 3>did law, as you said. And I realized I'd be

0:02:13.820 --> 0:02:16.910
<v Speaker 3>a terrible lawyer. So I quit. I joined a consulting firm,

0:02:16.940 --> 0:02:20.710
<v Speaker 3>as you say. Worked in Thailand, Indonesia, Mongolia, Los Angeles.

0:02:21.810 --> 0:02:24.310
<v Speaker 3>And it was for a kid from Perth, that was

0:02:24.350 --> 0:02:29.510
<v Speaker 3>a wonderful chance to see the world. I then did

0:02:29.530 --> 0:02:32.370
<v Speaker 3>my MBA in the States. And coming out of business school,

0:02:32.810 --> 0:02:35.160
<v Speaker 3>I was really close to one of my professors, an

0:02:35.200 --> 0:02:38.100
<v Speaker 3>Australian professor. And he said, you need to work for Bungie,

0:02:38.160 --> 0:02:40.860
<v Speaker 3>which was a global agribusiness company. I ended up doing

0:02:40.900 --> 0:02:44.160
<v Speaker 3>a few other things and becoming the global head of

0:02:44.200 --> 0:02:47.590
<v Speaker 3>strategy in M &amp; A for that business, Bungie. In

0:02:47.600 --> 0:02:52.109
<v Speaker 3>that role, I managed to sell their fertilizer business, which

0:02:52.130 --> 0:02:54.609
<v Speaker 3>was in Brazil. We got just an unbelievable amount of

0:02:54.650 --> 0:02:56.929
<v Speaker 3>money for it, like way more than anyone was expecting.

0:02:57.730 --> 0:03:02.989
<v Speaker 3>A different fertilizer business was looking for a head of

0:03:03.010 --> 0:03:04.990
<v Speaker 3>strategy in M &amp; A, and they said he can't

0:03:05.010 --> 0:03:07.110
<v Speaker 3>be that bad if he got that sort of deal done.

0:03:07.930 --> 0:03:10.990
<v Speaker 3>I ended up going to Chicago and working with CF Industries,

0:03:11.010 --> 0:03:15.010
<v Speaker 3>the world's largest nitrogen fertilizer company. And that's when, you

0:03:15.030 --> 0:03:19.770
<v Speaker 3>may not realize this, but nitrogen fertilizer and explosives are

0:03:19.790 --> 0:03:24.200
<v Speaker 3>chemically identical. So I came back to Australia to join Orica,

0:03:24.340 --> 0:03:28.760
<v Speaker 3>which is the world's largest explosives company. And after some

0:03:28.800 --> 0:03:31.560
<v Speaker 3>time heading up strategy in chemicals here in Melbourne, I

0:03:31.600 --> 0:03:36.840
<v Speaker 3>then was tasked with leading Orica Asia. And again, very fortunate,

0:03:37.670 --> 0:03:41.830
<v Speaker 3>to have a terrific run there. And that's probably where

0:03:42.570 --> 0:03:46.310
<v Speaker 3>the eBoss connection starts to make a little bit more sense.

0:03:47.530 --> 0:03:52.780
<v Speaker 3>Orica Asia was a business of about 3,500 people covering

0:03:52.780 --> 0:04:00.280
<v Speaker 3>15 countries, about 20 small businesses contained in that. And

0:04:01.380 --> 0:04:04.400
<v Speaker 3>the thing that binds all those tiles together was a

0:04:04.460 --> 0:04:08.550
<v Speaker 3>regulated supply chain. You can... You can't store explosives for

0:04:08.570 --> 0:04:10.170
<v Speaker 3>too long, and you can't have too much in the

0:04:10.210 --> 0:04:13.500
<v Speaker 3>same place. So every day you need to be delivering

0:04:13.970 --> 0:04:17.560
<v Speaker 3>those explosives to keep the mines running. And then you

0:04:17.580 --> 0:04:23.159
<v Speaker 3>come to eBoss. So eBoss is 6,000 people across nine countries.

0:04:23.380 --> 0:04:27.520
<v Speaker 3>It's about 40 small businesses, but all based on this

0:04:27.980 --> 0:04:30.500
<v Speaker 3>highly regulated supply chain where you need to be delivering

0:04:31.170 --> 0:04:36.520
<v Speaker 3>the medicines, the implants, the... pet nutrition every day in

0:04:36.560 --> 0:04:39.760
<v Speaker 3>order to keep the surgeons, the hospitals, the very friends

0:04:40.180 --> 0:04:44.580
<v Speaker 3>of Australia and New Zealand and Southeast Asia nurtured and

0:04:44.620 --> 0:04:46.760
<v Speaker 3>cared for. And the more I talked about it with

0:04:46.779 --> 0:04:49.220
<v Speaker 3>the board, the more we saw that commonality and we

0:04:49.240 --> 0:04:52.120
<v Speaker 3>thought this could be pretty interesting. And it's turned out

0:04:52.140 --> 0:04:52.540
<v Speaker 3>to be that way.

0:04:53.690 --> 0:04:57.630
<v Speaker 1>So that background has really fed into the way that

0:04:57.670 --> 0:05:02.430
<v Speaker 1>you've thought about the vision for eBoss. And you've articulated that,

0:05:02.550 --> 0:05:06.570
<v Speaker 1>I guess, most clearly at the Investor Day back in April,

0:05:06.810 --> 0:05:10.010
<v Speaker 1>where there you set out a model, which was based

0:05:10.110 --> 0:05:15.940
<v Speaker 1>on three pillars. So care, partnerships, and productivity. Can you

0:05:15.960 --> 0:05:18.719
<v Speaker 1>talk us through what that means? What is that vision?

0:05:19.000 --> 0:05:23.480
<v Speaker 3>Oh, absolutely. And So when I arrived, the executive leadership

0:05:23.500 --> 0:05:25.320
<v Speaker 3>team and I spent quite a bit of time, I

0:05:25.360 --> 0:05:30.219
<v Speaker 3>would say, discovering or articulating what the purpose was. We

0:05:30.240 --> 0:05:34.590
<v Speaker 3>didn't enforce it or draw up a new one. It

0:05:34.630 --> 0:05:37.529
<v Speaker 3>was more, when you look at all these businesses, what

0:05:37.589 --> 0:05:43.270
<v Speaker 3>is common is this devotion to care, whether that's a

0:05:43.310 --> 0:05:46.909
<v Speaker 3>human or a pet. And so we've set our purposes...

0:05:48.540 --> 0:05:52.240
<v Speaker 3>to connect people, pets and communities to outstanding care anywhere.

0:05:53.220 --> 0:05:55.480
<v Speaker 3>And then the way we do that is through those

0:05:55.520 --> 0:05:59.060
<v Speaker 3>three pillars that you mentioned. Care, because that's a growing market.

0:05:59.320 --> 0:06:03.750
<v Speaker 3>That's a place where humans and pets are getting older

0:06:03.790 --> 0:06:06.070
<v Speaker 3>each year. They need more support and we're delighted to

0:06:06.089 --> 0:06:09.290
<v Speaker 3>be there for them. Productivity, because all the businesses that

0:06:09.330 --> 0:06:11.410
<v Speaker 3>we're in are highly competitive. And so we have to

0:06:11.450 --> 0:06:15.190
<v Speaker 3>focus on being efficient every day in what we do

0:06:15.370 --> 0:06:18.070
<v Speaker 3>so that we can keep delivering at the lowest cost.

0:06:18.920 --> 0:06:22.120
<v Speaker 3>And then through partnerships. And this one is probably a

0:06:22.160 --> 0:06:25.039
<v Speaker 3>little bit of a distinguishing feature versus some of our competitors,

0:06:25.160 --> 0:06:29.719
<v Speaker 3>because we love collaborating with other people in our value

0:06:29.740 --> 0:06:33.500
<v Speaker 3>chains to find new opportunities. So whether that's with suppliers

0:06:33.540 --> 0:06:35.659
<v Speaker 3>to bring the best technology to market or with puppy

0:06:35.700 --> 0:06:39.220
<v Speaker 3>breeders to get the best nutrition in the hands of

0:06:39.440 --> 0:06:43.460
<v Speaker 3>newborn puppies or with surgeons to make sure that we're

0:06:43.480 --> 0:06:47.859
<v Speaker 3>bringing them the latest in medical technology. It's those partnerships

0:06:47.880 --> 0:06:50.040
<v Speaker 3>that I think bring to life the business's success.

0:06:50.140 --> 0:06:51.820
<v Speaker 1>I think for some of our viewers who might be

0:06:51.900 --> 0:06:55.100
<v Speaker 1>less familiar with EBOS, are you able to take us

0:06:55.140 --> 0:06:58.640
<v Speaker 1>through at a very high level what those business divisions

0:06:58.880 --> 0:07:00.130
<v Speaker 1>are and what they do?

0:07:00.170 --> 0:07:05.550
<v Speaker 3>We have two reporting segments and then within there, four divisions.

0:07:05.570 --> 0:07:07.830
<v Speaker 3>The first one is Symbian and Healthcare Distribution. Think of

0:07:07.890 --> 0:07:12.290
<v Speaker 3>that as Australia and New Zealand's probably equal largest medicine

0:07:12.330 --> 0:07:15.940
<v Speaker 3>wholesaler and supplier. So Anytime that medicine flows to a

0:07:16.300 --> 0:07:18.560
<v Speaker 3>patient or a hospital, we're in there and about a

0:07:18.620 --> 0:07:23.850
<v Speaker 3>third of both markets. In retail pharmacy brands, we have

0:07:23.880 --> 0:07:29.750
<v Speaker 3>about 780 different pharmacy franchisees. And under the Terry White

0:07:29.790 --> 0:07:34.790
<v Speaker 3>label or Sink Cotter or MediAdvice, we're delighted that we're

0:07:34.810 --> 0:07:38.310
<v Speaker 3>a significant part of the pharmacies in Australia. And then

0:07:38.870 --> 0:07:42.770
<v Speaker 3>in medical technology in New Zealand and Australia and Southeast Asia,

0:07:44.100 --> 0:07:48.720
<v Speaker 3>We're probably the leading independent supplier of medical technology. So

0:07:48.760 --> 0:07:54.020
<v Speaker 3>think of that as being the link between those geniuses

0:07:54.060 --> 0:07:57.400
<v Speaker 3>who are developing new medical technologies and the surgeons and

0:07:57.430 --> 0:08:00.310
<v Speaker 3>hospitals and patients who need them across the region. We

0:08:00.330 --> 0:08:04.870
<v Speaker 3>provide that link. And then finally, animal care. And there

0:08:04.910 --> 0:08:08.210
<v Speaker 3>we are, Australia and New Zealand's largest vet wholesaler and

0:08:08.270 --> 0:08:11.530
<v Speaker 3>Australia's best loved dog food, which is Blackhawk. which is

0:08:11.630 --> 0:08:16.570
<v Speaker 3>Australia's actually largest dry dog food by volume. So it

0:08:16.630 --> 0:08:19.600
<v Speaker 3>is a range of businesses, but all bound together by care.

0:08:19.840 --> 0:08:22.320
<v Speaker 1>I want to dig into the distribution side a little

0:08:22.360 --> 0:08:27.320
<v Speaker 1>bit more. It's high volume and lower margin by nature.

0:08:27.500 --> 0:08:31.640
<v Speaker 1>And so operating at scale is really important there. If

0:08:31.680 --> 0:08:35.780
<v Speaker 1>we trace the medicine from the manufacturer right through to

0:08:35.820 --> 0:08:39.350
<v Speaker 1>the patient, Can you explain for us where does EBOS

0:08:39.710 --> 0:08:42.670
<v Speaker 1>sit within that picture and what is the edge that

0:08:42.690 --> 0:08:43.130
<v Speaker 1>it brings?

0:08:43.470 --> 0:08:47.910
<v Speaker 3>Sure. Let's say a global manufacturer of statin for high cholesterol.

0:08:48.410 --> 0:08:54.810
<v Speaker 3>They will have a contract with EBOS to manage that

0:08:54.870 --> 0:08:58.790
<v Speaker 3>supply in Australia and New Zealand. And so we run

0:08:58.809 --> 0:09:02.290
<v Speaker 3>a warehouse that effectively acts as an extension of their network.

0:09:02.809 --> 0:09:06.410
<v Speaker 3>So we have to live up to their conditions. So

0:09:06.429 --> 0:09:08.589
<v Speaker 3>they have very strict on how they want their warehouse run.

0:09:09.210 --> 0:09:11.250
<v Speaker 3>But we'll have about 50 of those in the same warehouse.

0:09:11.350 --> 0:09:13.110
<v Speaker 3>So we have to live up to 50 different standards.

0:09:14.050 --> 0:09:15.690
<v Speaker 3>And we do a great job of that in our

0:09:15.890 --> 0:09:19.420
<v Speaker 3>contract logistics business. On their behalf then, we will then

0:09:19.520 --> 0:09:23.240
<v Speaker 3>ship to Symbian and Symbian will then purchase that statin

0:09:24.220 --> 0:09:27.839
<v Speaker 3>and put it in one of our facilities, including Australia's

0:09:27.900 --> 0:09:31.440
<v Speaker 3>most modern medicine facility, which is medicine distribution facility, which

0:09:31.500 --> 0:09:36.350
<v Speaker 3>is Kemp's Creek outside of Sydney. And they're We try

0:09:36.390 --> 0:09:39.360
<v Speaker 3>and drive productivity through the most automated approach that we

0:09:39.390 --> 0:09:44.580
<v Speaker 3>can take. And every morning we will have received 10,000

0:09:44.580 --> 0:09:50.099
<v Speaker 3>to 15,000 new orders that change every day. And by

0:09:50.100 --> 0:09:52.420
<v Speaker 3>6 a.m., 7 a.m., those orders are on the road

0:09:52.850 --> 0:09:56.990
<v Speaker 3>being shipped, including our statin that you've asked for. And

0:09:57.270 --> 0:09:59.650
<v Speaker 3>that'll get delivered to the pharmacies and hospitals across Australia,

0:09:59.670 --> 0:10:04.160
<v Speaker 3>including some Terry White pharmacies and that's where Terry White

0:10:04.540 --> 0:10:07.679
<v Speaker 3>which is just beloved in the Australian community for care

0:10:08.260 --> 0:10:11.179
<v Speaker 3>people often come in and talk to the pharmacist about

0:10:11.200 --> 0:10:15.120
<v Speaker 3>the script that they've received and also how it interacts

0:10:15.140 --> 0:10:18.270
<v Speaker 3>with their other medicines or with their lifestyle so for

0:10:18.290 --> 0:10:21.450
<v Speaker 3>example the statin is dehydrating, then we would offer some

0:10:22.870 --> 0:10:30.240
<v Speaker 3>hydration or nutrition opportunities as well. So it's one little pill,

0:10:30.860 --> 0:10:34.050
<v Speaker 3>but we're delighted to be there every step of the way. Yes.

0:10:34.070 --> 0:10:36.839
<v Speaker 1>I mean, so critical for the customers and the patients.

0:10:36.860 --> 0:10:40.130
<v Speaker 3>That's right. We pride ourselves on, with this care, we

0:10:40.170 --> 0:10:42.520
<v Speaker 3>don't want to be seen as someone that's remote from

0:10:42.540 --> 0:10:44.920
<v Speaker 3>the customer. I don't know if you remember the bad

0:10:45.000 --> 0:10:49.120
<v Speaker 3>old pharmacists of the 90s. You'd walk into the pharmacy

0:10:49.140 --> 0:10:51.160
<v Speaker 3>and then at the back, there'd be like a raised

0:10:51.220 --> 0:10:53.679
<v Speaker 3>podium and a screen, and then you'd sort of worship

0:10:53.720 --> 0:10:56.400
<v Speaker 3>at the podium and be blessed with the medicine. We

0:10:56.420 --> 0:10:59.420
<v Speaker 3>don't do that at Terry White. The pharmacist and the

0:10:59.440 --> 0:11:02.080
<v Speaker 3>pharmacy assistants are constantly on the floor, trying to engage

0:11:02.140 --> 0:11:06.640
<v Speaker 3>with our shoppers who love coming in and say, oh, Mrs. Smith,

0:11:06.660 --> 0:11:08.400
<v Speaker 3>good to see you again. What's brought you in today?

0:11:08.480 --> 0:11:09.380
<v Speaker 3>What can we help with?

0:11:09.420 --> 0:11:10.120
<v Speaker 1>Yeah, that's right.

0:11:10.240 --> 0:11:12.939
<v Speaker 3>And that is, I think, back to your point earlier,

0:11:13.000 --> 0:11:14.510
<v Speaker 3>that's the point of differentiation for us.

0:11:14.580 --> 0:11:17.490
<v Speaker 1>I just want to pause on animal care because it's

0:11:17.510 --> 0:11:22.090
<v Speaker 1>an interesting segment and growing quite rapidly. So revenue in

0:11:22.570 --> 0:11:26.609
<v Speaker 1>animal care grew over 30% last financial year. Can you

0:11:26.650 --> 0:11:28.970
<v Speaker 1>talk us through what's driving that growth?

0:11:29.590 --> 0:11:35.110
<v Speaker 3>So animal care began for EBOS as a wonderful extension

0:11:35.150 --> 0:11:37.310
<v Speaker 3>of this commitment to medicines. And so we had gotten

0:11:37.330 --> 0:11:42.060
<v Speaker 3>into the business of supplying animal medicines, which was analogous

0:11:42.100 --> 0:11:44.780
<v Speaker 3>to our Symbian business. And then we noticed that more

0:11:44.820 --> 0:11:47.719
<v Speaker 3>and more of our vets and patients needed quality nutrition.

0:11:48.160 --> 0:11:52.390
<v Speaker 3>And then that led to our wonderful Blackhawk brand. So

0:11:52.429 --> 0:11:56.910
<v Speaker 3>that's how we got into the business. And then what

0:11:56.950 --> 0:12:01.929
<v Speaker 3>we see as the growth continues those two streams. In

0:12:01.980 --> 0:12:05.840
<v Speaker 3>that vet wholesaling side, we were always Australia's largest vet wholesaler,

0:12:05.920 --> 0:12:09.440
<v Speaker 3>but about 15 months ago, we bought New Zealand's largest

0:12:09.460 --> 0:12:12.480
<v Speaker 3>wholesaler of vet medicines, SVS, which has just turned out

0:12:12.500 --> 0:12:15.360
<v Speaker 3>to be a cracker. A wonderful business run by a

0:12:15.420 --> 0:12:19.520
<v Speaker 3>great team, John and Emma, and they do a great job.

0:12:20.040 --> 0:12:23.410
<v Speaker 3>And that's part of the reason the revenue grew 30%.

0:12:23.410 --> 0:12:25.950
<v Speaker 3>Like you said at the beginning, the wholesale business is

0:12:26.010 --> 0:12:28.480
<v Speaker 3>high revenue low margins. So if you can imagine that

0:12:29.860 --> 0:12:31.719
<v Speaker 3>high revenue business was not part of animal care and

0:12:31.740 --> 0:12:33.040
<v Speaker 3>then all of a sudden is part of animal care,

0:12:33.460 --> 0:12:38.140
<v Speaker 3>that's a big driver of that 30% increase. Now with

0:12:38.179 --> 0:12:40.569
<v Speaker 3>that footprint, I think we feel comfortable that we've done

0:12:40.610 --> 0:12:44.870
<v Speaker 3>the right acquisitions. But in branded animal care, I think

0:12:44.910 --> 0:12:48.090
<v Speaker 3>we have a wonderful set of opportunities. One thing that

0:12:48.110 --> 0:12:52.050
<v Speaker 3>we've been really good at is taking that existing Blackhawk brand,

0:12:52.290 --> 0:12:57.150
<v Speaker 3>that really trusted, beloved premium brand, and then bringing it

0:12:57.190 --> 0:13:00.510
<v Speaker 3>to new categories. So our market share is about a

0:13:02.110 --> 0:13:04.930
<v Speaker 3>quarter in dry dog food. And then we've been able

0:13:04.970 --> 0:13:10.980
<v Speaker 3>to extend into, for example, healthy benefits, which is where

0:13:11.020 --> 0:13:15.460
<v Speaker 3>you have dog food that addresses itchy skin or an

0:13:15.520 --> 0:13:22.810
<v Speaker 3>overweight pet. And we went from zero to closer to 20%

0:13:22.809 --> 0:13:26.030
<v Speaker 3>of market within two years without much marketing support, just

0:13:26.090 --> 0:13:29.970
<v Speaker 3>driven by that halo position from the Blackhawk brand. But wait,

0:13:29.990 --> 0:13:33.569
<v Speaker 3>there's more, because what that team found was with that

0:13:33.630 --> 0:13:38.390
<v Speaker 3>marketing expertise, they could plug in additional manufacturing. And that's

0:13:38.410 --> 0:13:40.530
<v Speaker 3>what we did a year ago with an acquisition called

0:13:40.570 --> 0:13:45.390
<v Speaker 3>NextGen Pet Food. Think of this as two crazy guys

0:13:45.429 --> 0:13:48.150
<v Speaker 3>who are great at manufacturing pet food just outside Toowoomba

0:13:48.570 --> 0:13:52.610
<v Speaker 3>in Queensland, but they didn't have a brand. They didn't

0:13:52.630 --> 0:13:54.770
<v Speaker 3>have a way to bring it to market. And so

0:13:54.830 --> 0:13:57.520
<v Speaker 3>we were able to buy NextGen And then hook that

0:13:57.580 --> 0:14:00.500
<v Speaker 3>up to Blackhawk. In six months, we got 5% market

0:14:00.520 --> 0:14:04.750
<v Speaker 3>share in air-dried, freeze-dried treats. We do manufacturing and marketing.

0:14:05.710 --> 0:14:08.950
<v Speaker 3>If we can find bolt-on opportunities where one of those

0:14:09.030 --> 0:14:12.050
<v Speaker 3>is not good enough, where there's a great manufacturer who's

0:14:12.070 --> 0:14:13.750
<v Speaker 3>not good at marketing, a great marketer who's not good

0:14:13.770 --> 0:14:17.030
<v Speaker 3>at manufacturing, that's a natural bolt-on opportunity in branded animal care.

0:14:17.080 --> 0:14:19.920
<v Speaker 3>And I think pretty exciting for us to go forward.

0:14:20.270 --> 0:14:24.160
<v Speaker 1>Healthcare is often described as defensive. And of course, in

0:14:24.220 --> 0:14:28.500
<v Speaker 1>Australia and New Zealand, backed by really positive demographic tailwinds

0:14:29.140 --> 0:14:32.979
<v Speaker 1>with an ageing population. Where do you see the opportunities

0:14:33.480 --> 0:14:37.570
<v Speaker 1>for EBOS as it relates to this demographic shift that

0:14:37.610 --> 0:14:38.070
<v Speaker 1>we're seeing?

0:14:38.090 --> 0:14:40.930
<v Speaker 3>I think that's right. The two great macro drivers are one,

0:14:41.630 --> 0:14:46.110
<v Speaker 3>ageing population. Just normally, as you get older, you need

0:14:46.130 --> 0:14:48.760
<v Speaker 3>more care. And so more medicines, and we're happy to

0:14:48.780 --> 0:14:54.370
<v Speaker 3>supply that. More implants, happy to supply that. More engagement

0:14:54.390 --> 0:14:58.510
<v Speaker 3>with your pharmacist. But also, we're not the only people

0:14:58.530 --> 0:15:02.810
<v Speaker 3>who've noticed that. And so the global medical technology, pharmaceutical

0:15:03.230 --> 0:15:08.110
<v Speaker 3>companies have invested billions in new drugs, new implants to

0:15:08.130 --> 0:15:11.910
<v Speaker 3>help serve that population. And we're positioned at the forefront

0:15:11.930 --> 0:15:14.090
<v Speaker 3>of that. So we're able to bring those to market

0:15:15.510 --> 0:15:20.880
<v Speaker 3>for those people. including the GLP-1 craze, for example. And

0:15:21.400 --> 0:15:23.320
<v Speaker 3>then if I turn to pets, the other thing that

0:15:23.380 --> 0:15:28.410
<v Speaker 3>people sometimes miss, people get the COVID-era pet boom. Those

0:15:28.470 --> 0:15:31.690
<v Speaker 3>pets are just starting middle age now. And so they're

0:15:31.710 --> 0:15:35.170
<v Speaker 3>going to need more love, more medicines, and we're happy

0:15:35.190 --> 0:15:36.570
<v Speaker 3>to help with at least the medicine side of that.

0:15:39.210 --> 0:15:41.670
<v Speaker 3>But also that means that they then live longer. So

0:15:42.770 --> 0:15:46.410
<v Speaker 3>quite interestingly, pet lives have extended by 10% to 15%.

0:15:46.410 --> 0:15:48.690
<v Speaker 3>over the last five years. And so I think that's

0:15:48.730 --> 0:15:52.120
<v Speaker 3>a really meaningful opportunity as well in terms of caring

0:15:52.130 --> 0:15:56.240
<v Speaker 3>for them in that older age era. So I see

0:15:56.260 --> 0:15:59.520
<v Speaker 3>the macro trend demographically actually pretty positive for us. Yeah.

0:16:00.200 --> 0:16:04.490
<v Speaker 1>You mentioned a massive trend around GLP drugs. How has

0:16:04.590 --> 0:16:08.530
<v Speaker 1>it sort of influenced your volumes, your margin, and even

0:16:08.570 --> 0:16:11.690
<v Speaker 1>as you think about distribution and how those drugs are

0:16:11.730 --> 0:16:13.530
<v Speaker 1>stored and delivered and things like that?

0:16:14.330 --> 0:16:17.600
<v Speaker 3>The market that adopted the GLP-1's first was the United States.

0:16:18.250 --> 0:16:21.720
<v Speaker 3>And my understanding is in the US, between 10% and 12%

0:16:21.720 --> 0:16:25.280
<v Speaker 3>of the adult population is on GLP-1s right now. And

0:16:25.320 --> 0:16:33.160
<v Speaker 3>that's predominantly, but not exclusively, the weekly cold chain injectable format. Now,

0:16:34.340 --> 0:16:38.160
<v Speaker 3>in Australia, the comparable figure is between 3% and 4%.

0:16:38.160 --> 0:16:40.340
<v Speaker 3>And in New Zealand, it's between 1% and 2% because

0:16:40.400 --> 0:16:44.830
<v Speaker 3>New Zealand came to GLP-1s a little later. And so

0:16:45.190 --> 0:16:47.130
<v Speaker 3>the opportunity in Australia and New Zealand is at least

0:16:47.170 --> 0:16:50.910
<v Speaker 3>probably 3x, just to catch up to where the US is,

0:16:50.960 --> 0:16:53.400
<v Speaker 3>and the US is still growing. So you're seeing these

0:16:53.520 --> 0:16:58.160
<v Speaker 3>tremendous growth rates in usage on GLP-1s. We have the

0:16:58.200 --> 0:17:01.720
<v Speaker 3>capacity to deliver those weekly cold-chain injectables today, and we

0:17:01.760 --> 0:17:08.160
<v Speaker 3>also have a tremendously productive dispatch of pills. And so

0:17:08.460 --> 0:17:13.649
<v Speaker 3>as either of those two formats grow, we're well-positioned. And

0:17:13.670 --> 0:17:14.990
<v Speaker 3>I think it's still a little bit in the balance.

0:17:15.630 --> 0:17:18.460
<v Speaker 3>Australia hasn't yet approved the pill form, but they have

0:17:18.480 --> 0:17:20.620
<v Speaker 3>in the UK. And the UK growth of the pill

0:17:20.660 --> 0:17:25.900
<v Speaker 3>form was actually faster than the weekly injectable. And so

0:17:25.940 --> 0:17:28.050
<v Speaker 3>that'll be really interesting to see how that plays out

0:17:28.470 --> 0:17:31.350
<v Speaker 3>in Australia and New Zealand. The one thing I would

0:17:31.450 --> 0:17:35.590
<v Speaker 3>add is GLP-1 growth is good, but it sometimes camouflages

0:17:37.100 --> 0:17:40.330
<v Speaker 3>high value medicine growth. So although a GLP-1 is like

0:17:40.330 --> 0:17:43.230
<v Speaker 3>$ 500 to $ 700, that's actually not a high value medicine

0:17:43.250 --> 0:17:45.410
<v Speaker 3>for us. We think of high value medicines as sort

0:17:45.430 --> 0:17:48.700
<v Speaker 3>of $ 700 plus. And you can have a single dose

0:17:48.760 --> 0:17:53.520
<v Speaker 3>worth up to $ 10, 000 of certain key oncology drugs. And

0:17:53.580 --> 0:17:56.700
<v Speaker 3>if you remember, I talked about those global pharmaceutical companies.

0:17:57.280 --> 0:17:59.359
<v Speaker 3>They're bringing more and more of these drugs to market.

0:17:59.420 --> 0:18:02.980
<v Speaker 3>They're really making a difference to people's lives. And those

0:18:03.020 --> 0:18:06.320
<v Speaker 3>have grown actually 11% over the last five years and

0:18:06.340 --> 0:18:11.649
<v Speaker 3>are now 40% of Australia's PBS. So a lot of

0:18:11.690 --> 0:18:14.850
<v Speaker 3>attention on GLP-1s, which is right and correct, but also

0:18:14.890 --> 0:18:19.550
<v Speaker 3>the high value medicines. And between the two, the companies

0:18:19.570 --> 0:18:21.410
<v Speaker 3>that are going to benefit are going to be the

0:18:21.810 --> 0:18:26.340
<v Speaker 3>nationwide scale, highly productive operators. And we're at the forefront there.

0:18:27.180 --> 0:18:31.090
<v Speaker 1>You mentioned the role of pharmacies and how they're evolving

0:18:31.130 --> 0:18:36.429
<v Speaker 1>and shifting to providing more care, more clinical services. So vaccinations,

0:18:36.690 --> 0:18:41.460
<v Speaker 1>health checks, and even prescribing for common conditions. How does

0:18:41.640 --> 0:18:45.419
<v Speaker 1>eBoss support the likes of the Terry White Chem Mart

0:18:46.020 --> 0:18:48.659
<v Speaker 1>as they make that shift and they provide more of

0:18:48.700 --> 0:18:50.600
<v Speaker 1>those services to customers?

0:18:50.800 --> 0:18:54.200
<v Speaker 3>Yeah, it's really interesting because we've made a strategic choice

0:18:54.850 --> 0:18:57.619
<v Speaker 3>that costs us money. Yep. but it gives us a

0:18:57.660 --> 0:19:00.240
<v Speaker 3>big benefit. And that choice is that in almost every

0:19:00.280 --> 0:19:02.600
<v Speaker 3>Terry White, there is what we call a care clinic.

0:19:03.359 --> 0:19:07.850
<v Speaker 3>We've reserved part of the store footprint, precious real estate space,

0:19:08.770 --> 0:19:11.570
<v Speaker 3>and we put it aside as a private area behind

0:19:11.609 --> 0:19:14.230
<v Speaker 3>a door where someone can go to get a vaccination

0:19:14.290 --> 0:19:20.490
<v Speaker 3>or to get that prescription. And that commitment to pharmacists

0:19:20.670 --> 0:19:23.410
<v Speaker 3>who care and a space for them to deliver care

0:19:24.160 --> 0:19:27.300
<v Speaker 3>You can see that in the vaccination numbers. We're about 12%

0:19:27.300 --> 0:19:32.080
<v Speaker 3>of Australia's pharmacies, but we're 25% of Australia's pharmacist vaccinations.

0:19:32.340 --> 0:19:35.179
<v Speaker 3>So you can see we're wildly overrepresented in terms of

0:19:36.060 --> 0:19:37.480
<v Speaker 3>what we can achieve in care.

0:19:38.030 --> 0:19:39.290
<v Speaker 1>So I just want to take a step back now

0:19:39.330 --> 0:19:43.010
<v Speaker 1>and just talk about the financials. You recently provided your

0:19:43.030 --> 0:19:47.169
<v Speaker 1>first full year financial results as a CEO. Could you

0:19:47.190 --> 0:19:49.550
<v Speaker 1>step us through what were some of the highlights from

0:19:49.590 --> 0:19:51.040
<v Speaker 1>your perspective? from that result?

0:19:51.320 --> 0:19:54.220
<v Speaker 3>Yeah, I'd say three key messages from the full year.

0:19:54.400 --> 0:19:57.720
<v Speaker 3>First was we delivered on guidance, both financially and operationally.

0:19:58.380 --> 0:20:00.980
<v Speaker 3>The second was we had great options in each of

0:20:01.020 --> 0:20:05.650
<v Speaker 3>our four divisions. Pardon me. And the third was we

0:20:05.690 --> 0:20:09.910
<v Speaker 3>have continued spare capacity for bolt-on M &amp; A, with

0:20:09.950 --> 0:20:12.560
<v Speaker 3>more to come. Just going back to that first one

0:20:12.580 --> 0:20:15.619
<v Speaker 3>of delivering on guidance, we set a target range of

0:20:15.660 --> 0:20:17.820
<v Speaker 3>EBITDA for the year and we hit that. But we

0:20:17.880 --> 0:20:22.490
<v Speaker 3>also had said that during FY25, we would complete a

0:20:22.690 --> 0:20:26.110
<v Speaker 3>major capital program, a DC renewal program worth $ 360 million.

0:20:26.290 --> 0:20:30.109
<v Speaker 3>And we committed to that being completed by the 30th

0:20:30.130 --> 0:20:32.780
<v Speaker 3>of June, and it was. So all facilities, all eight

0:20:32.820 --> 0:20:37.379
<v Speaker 3>facilities were operational on that day. So as a result...

0:20:37.460 --> 0:20:41.690
<v Speaker 3>That then means in 2027, our CapEx bill steps down dramatically.

0:20:42.050 --> 0:20:45.350
<v Speaker 3>So it goes down from circa 150 million to circa

0:20:45.350 --> 0:20:48.470
<v Speaker 3>100 million. So it drops by a third. And the

0:20:48.530 --> 0:20:50.510
<v Speaker 3>investors know that and they're excited by it to see

0:20:50.590 --> 0:20:54.640
<v Speaker 3>us using less cash to generate the same returns. Then

0:20:54.680 --> 0:20:59.060
<v Speaker 3>in terms of the four divisions, I mentioned each of

0:20:59.080 --> 0:21:00.560
<v Speaker 3>them just a moment ago, but they've all got great

0:21:00.660 --> 0:21:04.460
<v Speaker 3>options for growth. Symbian is putting those new assets to work.

0:21:05.200 --> 0:21:07.359
<v Speaker 3>Those new facilities were all in the Symbian business, and

0:21:07.420 --> 0:21:10.399
<v Speaker 3>now they can continue to drive productivity or drive utilization.

0:21:11.280 --> 0:21:14.909
<v Speaker 3>In retail pharmacy brands, now we've got this network. It's

0:21:14.950 --> 0:21:20.510
<v Speaker 3>actually Australia's largest network of franchisees. We found there's more

0:21:20.609 --> 0:21:24.370
<v Speaker 3>ways to put that network to practice and to earn

0:21:24.390 --> 0:21:29.720
<v Speaker 3>more money through retail media, through private label, through online sales.

0:21:29.960 --> 0:21:32.500
<v Speaker 3>And we really haven't reached the limit of each of those.

0:21:33.170 --> 0:21:37.129
<v Speaker 3>So that's a wonderful opportunity for our pharmacists. And then

0:21:37.670 --> 0:21:41.030
<v Speaker 3>in medical technology, we've got new Allagraph products coming through

0:21:41.210 --> 0:21:43.750
<v Speaker 3>as well as new acquisitions. And then in animal care,

0:21:44.390 --> 0:21:47.290
<v Speaker 3>we've got some new products that are coming to market

0:21:47.850 --> 0:21:49.830
<v Speaker 3>off the back of an acquisition that we did at

0:21:49.850 --> 0:21:50.770
<v Speaker 3>the very end of 2026.

0:21:50.770 --> 0:21:56.960
<v Speaker 1>You've just wrapped up this $ 360 million CapEx program over

0:21:57.020 --> 0:22:01.690
<v Speaker 1>four years to modernize the distribution network. And Kemp's Creek

0:22:01.770 --> 0:22:03.610
<v Speaker 1>is now the flagship site.

0:22:03.670 --> 0:22:04.209
<v Speaker 3>That's right.

0:22:04.350 --> 0:22:08.070
<v Speaker 1>Practically speaking, can you tell us what can eBoss do

0:22:08.130 --> 0:22:11.830
<v Speaker 1>now or do better that it couldn't do, say, four

0:22:11.850 --> 0:22:12.290
<v Speaker 1>years ago?

0:22:12.630 --> 0:22:16.869
<v Speaker 3>And one of the ways that you look at productivity

0:22:17.470 --> 0:22:20.300
<v Speaker 3>for a medicine warehouse is you think about it in

0:22:20.359 --> 0:22:24.040
<v Speaker 3>terms of how many doses, and we call them lines,

0:22:24.440 --> 0:22:28.340
<v Speaker 3>how many doses can you get out for every person,

0:22:28.840 --> 0:22:31.159
<v Speaker 3>every hour of a person employed? And so the way

0:22:31.200 --> 0:22:33.760
<v Speaker 3>we think about that is what we call lines per

0:22:33.820 --> 0:22:36.980
<v Speaker 3>attended hour. So for every person that's there, how many

0:22:37.740 --> 0:22:41.790
<v Speaker 3>doses can you get out the door? And we measure

0:22:41.830 --> 0:22:44.870
<v Speaker 3>that very carefully at each of our facilities, not just

0:22:45.070 --> 0:22:48.190
<v Speaker 3>between facilities, but also sort of week to week or

0:22:48.230 --> 0:22:50.409
<v Speaker 3>day to day to make sure that each facility is

0:22:50.450 --> 0:22:54.510
<v Speaker 3>on track. And so I'm very confident in saying driving

0:22:54.550 --> 0:22:57.649
<v Speaker 3>that KPI is really what this investment was about at

0:22:57.690 --> 0:23:02.419
<v Speaker 3>Kim's Creek. And we've already achieved 20% more lines per

0:23:02.440 --> 0:23:06.900
<v Speaker 3>attended hour at Kimp's Creek in Sydney versus its predecessor site.

0:23:07.830 --> 0:23:10.850
<v Speaker 3>And so that's a great achievement. And we've publicly said

0:23:10.869 --> 0:23:13.899
<v Speaker 3>to the market, we'll hit 30% by the end of FY27.

0:23:13.910 --> 0:23:14.270
<v Speaker 3>So far on track.

0:23:16.140 --> 0:23:22.129
<v Speaker 1>You've earmarked around $ 150 million for Bolton acquisitions this coming

0:23:22.210 --> 0:23:23.169
<v Speaker 1>financial year.

0:23:24.030 --> 0:23:26.649
<v Speaker 3>I'd say up to. We're not committing to spend it,

0:23:26.690 --> 0:23:27.590
<v Speaker 3>but it's there.

0:23:27.630 --> 0:23:30.690
<v Speaker 1>Depends on what the opportunities are that arise, I guess.

0:23:30.710 --> 0:23:33.580
<v Speaker 1>Can we talk about what are you looking for and

0:23:33.660 --> 0:23:36.460
<v Speaker 1>what are the factors that you consider in terms of

0:23:36.760 --> 0:23:37.840
<v Speaker 1>what is a good opportunity?

0:23:37.859 --> 0:23:41.660
<v Speaker 3>Yes. And I think when you think about M &amp; A,

0:23:41.680 --> 0:23:44.440
<v Speaker 3>you've got to come back to Why is this a

0:23:44.440 --> 0:23:47.170
<v Speaker 3>good deal for shareholders? And eBoss is very fortunate that

0:23:47.190 --> 0:23:50.130
<v Speaker 3>there's a few different areas of synergy. One that you've

0:23:50.150 --> 0:23:53.170
<v Speaker 3>just mentioned, which is in animal care, it's about bringing

0:23:53.210 --> 0:23:56.250
<v Speaker 3>those two halves of marketing and manufacturing together. So anytime

0:23:56.270 --> 0:23:59.750
<v Speaker 3>that there's a bolt-on like Paringa, for example, that we

0:23:59.790 --> 0:24:06.090
<v Speaker 3>just bought, wonderful manufacturing site in Sydney, but no access

0:24:06.109 --> 0:24:09.900
<v Speaker 3>to the brands. Second synergy would be around bringing sort

0:24:09.920 --> 0:24:15.290
<v Speaker 3>of critical mass to individual players. And so in Retail Pharmacy,

0:24:15.330 --> 0:24:17.850
<v Speaker 3>we bought the Media Advice brand a year ago. And

0:24:17.890 --> 0:24:21.950
<v Speaker 3>that's because we had the scale to do private label

0:24:21.990 --> 0:24:24.570
<v Speaker 3>and retail media, and they did not. So by plugging

0:24:24.630 --> 0:24:28.600
<v Speaker 3>their branches into our existing retail media and private label network,

0:24:28.740 --> 0:24:31.740
<v Speaker 3>all of a sudden, able to create more synergies. And

0:24:31.760 --> 0:24:35.419
<v Speaker 3>then we've got pricing synergy. We've got access to deals

0:24:35.440 --> 0:24:39.199
<v Speaker 3>that others don't have. That's really weird and rare. But

0:24:39.240 --> 0:24:42.770
<v Speaker 3>in medical technology, because we've done so many buyouts, And

0:24:42.810 --> 0:24:45.270
<v Speaker 3>because the buyouts are typically structured as an earn out

0:24:45.369 --> 0:24:49.449
<v Speaker 3>of a family player, we're now known throughout Australia, New

0:24:49.470 --> 0:24:53.240
<v Speaker 3>Zealand and Southeast Asia as a trustworthy partner for a

0:24:53.280 --> 0:24:55.460
<v Speaker 3>distributor who wants to sell. So then they'll come to

0:24:55.500 --> 0:24:58.300
<v Speaker 3>us and they'll be like, oh, you know, I know Jennifer.

0:24:58.359 --> 0:25:01.960
<v Speaker 3>Jennifer sold her business to you and you did right

0:25:01.980 --> 0:25:03.800
<v Speaker 3>by her in terms of the earn out. I'd like

0:25:03.820 --> 0:25:05.899
<v Speaker 3>to sell my business to you. Can we work out

0:25:05.920 --> 0:25:09.570
<v Speaker 3>a deal? So quite often we're in bilateral negotiations that

0:25:09.619 --> 0:25:12.950
<v Speaker 3>can be complex and but are generally at a very

0:25:12.990 --> 0:25:15.070
<v Speaker 3>fair price for both the buyer and the seller. And

0:25:15.090 --> 0:25:18.850
<v Speaker 3>then finally, I think the other thing that I've noticed

0:25:19.369 --> 0:25:21.830
<v Speaker 3>through my career is there's businesses that are used to

0:25:21.970 --> 0:25:25.030
<v Speaker 3>M &amp; A and who are able to, I guess,

0:25:25.090 --> 0:25:28.169
<v Speaker 3>match fit, and businesses that it's a foreign concept, it's

0:25:28.190 --> 0:25:33.320
<v Speaker 3>a convulsion that they really struggle with. Thankfully, eBoss is

0:25:33.340 --> 0:25:35.920
<v Speaker 3>very much in the former camp and something that we

0:25:37.480 --> 0:25:39.909
<v Speaker 3>very much want to keep alive. as part of the

0:25:39.950 --> 0:25:40.270
<v Speaker 3>eBoss DNA.

0:25:40.290 --> 0:25:43.630
<v Speaker 1>Yeah, and it sounds like your background comes to fruition there.

0:25:43.730 --> 0:25:46.730
<v Speaker 1>I heard a lot of synergies and partnerships and all

0:25:46.810 --> 0:25:47.889
<v Speaker 1>of those right words.

0:25:48.290 --> 0:25:50.470
<v Speaker 3>Look, if I had to add one more thing about

0:25:50.490 --> 0:25:56.280
<v Speaker 3>the business, it's quite interesting the impact that the large

0:25:56.320 --> 0:25:59.820
<v Speaker 3>capital program that you've mentioned has on our financial statements.

0:26:00.220 --> 0:26:04.040
<v Speaker 3>So what it's done is our EBITDA, the way the

0:26:04.060 --> 0:26:07.959
<v Speaker 3>business earns money, has continued to grow. And we forecast

0:26:07.980 --> 0:26:11.359
<v Speaker 3>that to keep growing, including a 3% to 7% growth

0:26:11.520 --> 0:26:17.520
<v Speaker 3>in EBITDA in 2027. Our accounting profit is flat for

0:26:17.540 --> 0:26:19.960
<v Speaker 3>two years as a result of the new depreciation and

0:26:19.980 --> 0:26:22.900
<v Speaker 3>the new interest costs that we've got for that CapEx.

0:26:23.119 --> 0:26:24.419
<v Speaker 3>People who are just looking at the profit line and

0:26:24.440 --> 0:26:27.659
<v Speaker 3>missing the story, actually the growth continues at EBITDA. And

0:26:27.680 --> 0:26:30.100
<v Speaker 3>they want to invest with us and be part of

0:26:30.119 --> 0:26:32.290
<v Speaker 3>that journey and pick up a healthy dividend check.

0:26:32.510 --> 0:26:35.030
<v Speaker 1>It's easy to miss if you look at the margins

0:26:35.050 --> 0:26:37.530
<v Speaker 1>because it is a lower margin business by nature, but

0:26:37.570 --> 0:26:42.119
<v Speaker 1>it's the partnerships and the synergies and the volume that's

0:26:42.220 --> 0:26:43.040
<v Speaker 1>critically important.

0:26:43.119 --> 0:26:46.479
<v Speaker 3>You're exactly right. Those are the levers that drive that.

0:26:47.020 --> 0:26:48.200
<v Speaker 3>annual EBITDA growth agreement. Yeah.

0:26:48.340 --> 0:26:50.639
<v Speaker 1>I guess probably one more question, just as it relates

0:26:50.680 --> 0:26:54.050
<v Speaker 1>to the financials. If an investor is looking at this business,

0:26:54.270 --> 0:26:56.710
<v Speaker 1>what does success mean to you in terms of your

0:26:56.750 --> 0:26:59.250
<v Speaker 1>strategy and how do you measure that for EBOS?

0:26:59.490 --> 0:27:04.149
<v Speaker 3>Yeah. And I'd probably look to short-term, long-term. And I

0:27:04.190 --> 0:27:06.230
<v Speaker 3>would say in the short-term, you want to see EBITDA

0:27:06.250 --> 0:27:08.790
<v Speaker 3>growth each year. And in the long-term, you want to

0:27:08.830 --> 0:27:11.440
<v Speaker 3>see a return on capital employed. And our long-term target

0:27:11.480 --> 0:27:14.420
<v Speaker 3>is 15% return on capital employed, which is very healthy.

0:27:14.700 --> 0:27:18.270
<v Speaker 3>On the EBITDA growth, we've said mid-single-digit EBITDA growth that

0:27:18.310 --> 0:27:22.470
<v Speaker 3>we expect to continue. That's how the management team's incentives

0:27:22.490 --> 0:27:25.409
<v Speaker 3>are structured as well. So we only get paid or

0:27:25.430 --> 0:27:28.670
<v Speaker 3>we only get rewarded in proportion to that growth in

0:27:28.710 --> 0:27:32.550
<v Speaker 3>EBITDA each year, but also the long-term return on capital employed,

0:27:32.609 --> 0:27:35.150
<v Speaker 3>which is, I think, right. It aligns management and shareholders

0:27:35.210 --> 0:27:36.790
<v Speaker 3>in terms of driving the business forward.

0:27:36.990 --> 0:27:38.990
<v Speaker 1>We've covered a lot of ground, but we'd like to

0:27:39.109 --> 0:27:42.129
<v Speaker 1>end with a little round of rapid fire. So a

0:27:42.150 --> 0:27:45.930
<v Speaker 1>bit of fun, short answers and the first answer that

0:27:45.970 --> 0:27:51.380
<v Speaker 1>comes to your head. So truthful. What is the best

0:27:51.460 --> 0:27:54.240
<v Speaker 1>piece of business advice that you have been given in

0:27:54.280 --> 0:27:54.780
<v Speaker 1>your career?

0:27:56.260 --> 0:27:57.859
<v Speaker 3>Hire great people and get out of their way.

0:27:58.930 --> 0:28:03.520
<v Speaker 1>I love that. That's great. Is there a book, a podcast,

0:28:03.940 --> 0:28:06.980
<v Speaker 1>a movie that you're recommending to people at the moment?

0:28:07.480 --> 0:28:09.899
<v Speaker 3>The book that I have recommended the most to people

0:28:10.000 --> 0:28:12.540
<v Speaker 3>is a wonderful book called The Man Who Ate Everything.

0:28:13.080 --> 0:28:15.540
<v Speaker 3>And it is a great story about a man who

0:28:15.600 --> 0:28:20.550
<v Speaker 3>quite accidentally became the Vogue food editor. And he realized

0:28:20.590 --> 0:28:24.389
<v Speaker 3>that he disliked certain foods and thought, if I'm the

0:28:24.410 --> 0:28:26.949
<v Speaker 3>food editor, I can't dislike a certain food. I've got

0:28:26.970 --> 0:28:28.730
<v Speaker 3>to train myself to love it. So he went around

0:28:28.770 --> 0:28:32.389
<v Speaker 3>and ate only the foods that he hated for a

0:28:32.430 --> 0:28:34.129
<v Speaker 3>series of months until he grew to love them and

0:28:34.150 --> 0:28:36.510
<v Speaker 3>appreciate them for what they were. So it's a wonderful-

0:28:36.530 --> 0:28:38.410
<v Speaker 3>Interesting perspective. Yeah, yeah, yeah.

0:28:39.070 --> 0:28:40.510
<v Speaker 1>Topical, AI.

0:28:40.790 --> 0:28:41.030
<v Speaker 3>Yes.

0:28:41.310 --> 0:28:43.790
<v Speaker 1>Good or bad? And what do you use it for?

0:28:44.650 --> 0:28:47.650
<v Speaker 3>I think the focus on the rise of the clankers

0:28:47.830 --> 0:28:51.470
<v Speaker 3>is too black and white. We've always had automation in

0:28:51.510 --> 0:28:56.890
<v Speaker 3>our business. We've been doing these progressively more modern medicine

0:28:56.910 --> 0:29:01.670
<v Speaker 3>warehouses for 20 years. Using automation in what we do

0:29:01.710 --> 0:29:04.490
<v Speaker 3>every day is natural and part of being more efficient.

0:29:04.950 --> 0:29:07.460
<v Speaker 3>I'd say some of the more extreme AI claims we

0:29:07.480 --> 0:29:09.980
<v Speaker 3>steer away from, we're interested in, okay, how can we

0:29:10.000 --> 0:29:11.560
<v Speaker 3>deliver more medicine today more efficiently?

0:29:11.820 --> 0:29:15.219
<v Speaker 1>What is one thing that surprised you about being the

0:29:15.240 --> 0:29:17.760
<v Speaker 1>CEO of eBoss?

0:29:20.590 --> 0:29:24.850
<v Speaker 3>The commitment of the people at eBoss is really quite special.

0:29:25.570 --> 0:29:28.960
<v Speaker 3>Everybody here is here. They've got other options, but they're

0:29:29.000 --> 0:29:32.210
<v Speaker 3>here because they love delivering care to people. And whether

0:29:32.230 --> 0:29:37.390
<v Speaker 3>that's a newborn puppy or serving an elderly person coming

0:29:37.430 --> 0:29:40.380
<v Speaker 3>into a pharmacist or rushing life-saving medicines to a hospital,

0:29:40.780 --> 0:29:45.460
<v Speaker 3>it's because they love being part of helping others. And

0:29:45.620 --> 0:29:47.980
<v Speaker 3>I think that there's a magic in that within the

0:29:48.020 --> 0:29:50.920
<v Speaker 3>eBoss DNA. And it's something that we all rally around.

0:29:51.460 --> 0:29:53.800
<v Speaker 1>Well, thank you very much, Adam, for your time and

0:29:53.860 --> 0:29:57.210
<v Speaker 1>for hosting us in your offices. We've learnt a lot

0:29:57.230 --> 0:30:01.070
<v Speaker 1>about the business that is so critically important to Australians

0:30:01.170 --> 0:30:02.590
<v Speaker 1>and New Zealanders as well.

0:30:03.070 --> 0:30:05.030
<v Speaker 3>Thank you very much, Jackie. Really pleased to be here.

0:30:05.050 --> 0:30:05.310
<v Speaker 3>Thank you.

0:30:05.490 --> 0:30:05.810
<v Speaker 1>Thank you.